August 6, 2026

Medical Research and Clinical Trials

AI Breakthrough: UCLA Study Unveils Potential for Earlier Detection of Elusive Interval Breast Cancers ai-breakthrough-ucla-study-unveils-potential-for-earlier-detection-of-elusive-interval-breast-cancers

AI Breakthrough: UCLA Study Unveils Potential for Earlier Detection of Elusive Interval Breast Cancers

Reynand Wu July 19, 2026
Los Angeles, CA – A pioneering study spearheaded by investigators at the UCLA Health Jonsson Comprehensive Cancer...
Read More Read more about AI Breakthrough: UCLA Study Unveils Potential for Earlier Detection of Elusive Interval Breast Cancers
Landmark Cambridge Study Reveals Bilateral Salpingo-Oophorectomy Dramatically Boosts Survival for BRCA1/2 Breast Cancer Patients landmark-cambridge-study-reveals-bilateral-salpingo-oophorectomy-dramatically-boosts-survival-for-brca1-2-breast-cancer-patients-1

Landmark Cambridge Study Reveals Bilateral Salpingo-Oophorectomy Dramatically Boosts Survival for BRCA1/2 Breast Cancer Patients

Basiran July 18, 2026
Cambridge, UK – In a groundbreaking study published today in The Lancet Oncology, researchers from the University...
Read More Read more about Landmark Cambridge Study Reveals Bilateral Salpingo-Oophorectomy Dramatically Boosts Survival for BRCA1/2 Breast Cancer Patients
Takeda’s Oral Plaque Psoriasis Drug Zasocitinib Shows Significant Efficacy in Hard-to-Treat Areas, Bolstering Approval Prospects takedas-oral-plaque-psoriasis-drug-zasocitinib-shows-significant-efficacy-in-hard-to-treat-areas-bolstering-approval-prospects

Takeda’s Oral Plaque Psoriasis Drug Zasocitinib Shows Significant Efficacy in Hard-to-Treat Areas, Bolstering Approval Prospects

Basiran July 18, 2026
TOKYO, JAPAN – [Date of Publication] – Takeda Pharmaceutical Company Limited has unveiled compelling secondary endpoint data...
Read More Read more about Takeda’s Oral Plaque Psoriasis Drug Zasocitinib Shows Significant Efficacy in Hard-to-Treat Areas, Bolstering Approval Prospects
Salk Scientists Uncover Estrogen-Related Receptors as Key to Revitalizing Muscle Energy and Combating Fatigue salk-scientists-uncover-estrogen-related-receptors-as-key-to-revitalizing-muscle-energy-and-combating-fatigue

Salk Scientists Uncover Estrogen-Related Receptors as Key to Revitalizing Muscle Energy and Combating Fatigue

Raul Delapena Setiawan July 18, 2026
LA JOLLA, CA – May 12, 2025 – In a breakthrough that could redefine the treatment landscape...
Read More Read more about Salk Scientists Uncover Estrogen-Related Receptors as Key to Revitalizing Muscle Energy and Combating Fatigue
A New Dawn in Breast Cancer Treatment: Cambridge Breakthrough Offers 100% Survival for Aggressive Inherited Cancers a-new-dawn-in-breast-cancer-treatment-cambridge-breakthrough-offers-100-survival-for-aggressive-inherited-cancers

A New Dawn in Breast Cancer Treatment: Cambridge Breakthrough Offers 100% Survival for Aggressive Inherited Cancers

Nana July 17, 2026
Cambridge, UK – In a landmark development that could fundamentally alter the treatment landscape for patients with...
Read More Read more about A New Dawn in Breast Cancer Treatment: Cambridge Breakthrough Offers 100% Survival for Aggressive Inherited Cancers

You may have missed

a-challenging-tenure-begins-erica-schwartz-takes-the-helm-at-a-bifurcated-cdc

A Challenging Tenure Begins: Erica Schwartz Takes the Helm at a Bifurcated CDC

Reynand Wu August 6, 2026
the-erosion-of-global-health-diplomacy-an-analysis-of-the-post-usaid-landscape

The Erosion of Global Health Diplomacy: An Analysis of the Post-USAID Landscape

Reynand Wu August 6, 2026
the-quiet-revolution-reclaiming-well-being-through-the-art-of-deep-relaxation

The Quiet Revolution: Reclaiming Well-Being Through the Art of Deep Relaxation

Rifan Muazin August 6, 2026
a-new-era-for-breast-cancer-screening-pioneering-personalized-risk-assessment

A New Era for Breast Cancer Screening: Pioneering Personalized Risk Assessment

Laily UPN August 6, 2026